AMRI to Announce Fourth Quarter Results.

ALBANY, N.Y. -- Albany Molecular Research, Inc. (NASDAQ: AMRI) will report fourth quarter results before the opening of the market on Monday, February 12, 2007. The company will hold a conference call at 10:00 a.m. Eastern Time to discuss its quarterly financial results.

If you are interested in listening to the conference call, please dial 800-289-0726 (for domestic calls) or 913-981-5545 (for international calls) at 9:45 a.m. ET and provide conference code 4299861. In addition, the call is being webcast on the Internet and can be accessed on the company's website, www.albmolecular.com.

Replays of the call will be available for seven days following the call beginning at 12:00 p.m. on February 12, 2007. To access the replay by telephone, please call 888-203-1112 (for domestic calls) or 719-457-0820 (for international calls) and use passcode 4299861. In addition, replays of the call will be available as a webcast for three months in the investor area of the company's website at www.albmolecular.com/investor/investcc.html.

Founded in 1991, AMRI provides scientific services, technologies and products that improve quality of life while delivering excellence, value and maximum return. AMRI's core business consists of a fee-for service contract services platform encompassing drug discovery, development and manufacturing; and a separate, standalone R&D division comprising proprietary technologies, internal drug discovery and bundled capabilities designed for more collaborative relationships. With locations in the U.S., Europe, and Asia, AMRI provides customers with a range of services and cost models.